Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +6.45% | +10.00% | +5.60% |
Mar. 21 | Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M | MT |
Mar. 21 | Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Number of employees: 63
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 18-03-31 | |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
David Tanen
FOU | Founder | 52 | 17-06-01 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 23-09-14 |
Chief Tech/Sci/R&D Officer | 59 | 22-01-31 | |
Zung To
PRN | Corporate Officer/Principal | - | 20-04-30 |
Corporate Officer/Principal | - | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Tanen
FOU | Founder | 52 | 17-06-01 |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
Arie Belldegrun
FOU | Founder | 74 | 17-06-01 |
Tai Yin Yang
BRD | Director/Board Member | 70 | 21-03-24 |
Elena Ridloff
BRD | Director/Board Member | 44 | 20-09-14 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 20-12-31 |
Roger Dansey
BRD | Director/Board Member | 68 | 23-04-19 |
Katherine Stultz
BRD | Director/Board Member | 51 | 23-04-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,095,013 | 46,547,485 ( 77.46 %) | 0 | 77.46 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.60% | 74.52M | |
+9.35% | 45.97B | |
+52.73% | 43.93B | |
+7.37% | 42.34B | |
-8.78% | 28.27B | |
+18.40% | 27.18B | |
-21.53% | 19.44B | |
+14.59% | 13.83B | |
+32.16% | 12.4B | |
+5.58% | 11.45B |
- Stock
- Equities
- Stock Kronos Bio, Inc. - Nasdaq
- Company Kronos Bio, Inc.